Topic: regenerative medicine
Smith & Nephew plans to absorb regenerative medicine player Osiris Therapeutics in a $660 million deal to expand its wound care business.
University of Geneva scientists showed how pancreatic cells that normally don't produce insulin can be converted to produce the hormone.
NIH scientists pinpointed targets at six different “loci,” or genomic regions, that are related to the development of age-related macular degeneration.
A Stanford-led team identified a protein that helps small arteries grow, thereby healing oxygen-starved, damaged heart tissues in mice.
The National Eye Institute's stem cell-based therapy safely prevented blindness in animal models of age-related macular degeneration.
The Harvard researcher who first discovered the "exercise hormone" irisin reports it may be useful in bone formation.
The past week’s biotech news included a method for regrowing nerves by turning off genes and a potential combo to treat resistant lung cancer.
A team of Stanford University scientists has found a way to direct a regenerative diabetes medicine to the right cells more precisely.
The series D positions ViaCyte to generate phase 1/2 data on one candidate while working to get another back into the clinic.
MIT scientists designed a material that allows osteoarthritis drugs to more deeply penetrate cartilage-generating tissues.